Multiple lines of evidence strongly suggest that the accumulation of soluble low-molecular-weight Aβo plays a major role in neuronal hyperexcitability observed at the onset of AD, although other factors might also contribute, such as tau, other APP metabolites, APOE4, glial responses, neuroinflammation, and oxidative stress. The gene discussed is MAPT; the disease is Alzheimer disease.